author-photo

Akira Yokomizo

Kyushu University
Mayo Clinic

251

Papers

5011

Citations

Citation Trend

Filter By

Papers (179) Sort By

Journal Conference Others

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.

2021 International Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab.

2021 International Journal of Urology
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.

2021 Cancer Investigation
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.

2021 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: Results from a prospective cohort in the PRIAS-JAPAN study

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (26)
Prognostic impact of prior local therapy in castration-resistant prostate cancer.

2021 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study

2021 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (1)